1 Introduction to Research & Analysis Reports 1.1 Ethical Pharmaceuticals Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Ethical Pharmaceuticals Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Ethical Pharmaceuticals Overall Market Size 2.1 United States Ethical Pharmaceuticals Market Size: 2021 VS 2027 2.2 United States Ethical Pharmaceuticals Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Ethical Pharmaceuticals Players in United States Market 3.2 Top United States Ethical Pharmaceuticals Companies Ranked by Revenue 3.3 United States Ethical Pharmaceuticals Revenue by Companies 3.4 Top 3 and Top 5 Ethical Pharmaceuticals Companies in United States Market, by Revenue in 2020 3.5 Companies Ethical Pharmaceuticals Product Type 3.6 Tier 1, Tier 2 and Tier 3 Ethical Pharmaceuticals Players in United States Market 3.6.1 List of Tier 1 Ethical Pharmaceuticals Companies in United States 3.6.2 List of Tier 2 and Tier 3 Ethical Pharmaceuticals Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Ethical Pharmaceuticals Market Size Markets, 2021 & 2027 4.1.2 Lipid Regulators 4.1.3 Narcotic Analgesics 4.1.4 ACE Inhibitors 4.1.5 Respiratory Agents 4.1.6 Diuretics 4.1.7 Calcium Antagonists 4.1.8 Hormonal Contraceptives 4.1.9 Others 4.2 By Type - United States Ethical Pharmaceuticals Revenue & Forecasts 4.2.1 By Type - United States Ethical Pharmaceuticals Revenue, 2016-2021 4.2.2 By Type - United States Ethical Pharmaceuticals Revenue, 2022-2027 4.2.3 By Type - United States Ethical Pharmaceuticals Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Ethical Pharmaceuticals Market Size, 2021 & 2027 5.1.2 Hospitals 5.1.3 Clinics 5.1.4 Others 5.2 By Application - United States Ethical Pharmaceuticals Revenue & Forecasts 5.2.1 By Application - United States Ethical Pharmaceuticals Revenue, 2016-2021 5.2.2 By Application - United States Ethical Pharmaceuticals Revenue, 2022-2027 5.2.3 By Application - United States Ethical Pharmaceuticals Revenue Market Share, 2016-2027 6 Ethical Pharmaceuticals Companies Profiles 6.1 Teva Pharmaceutical Industries 6.1.1 Teva Pharmaceutical Industries Company Details 6.1.2 Teva Pharmaceutical Industries Business Overview 6.1.3 Teva Pharmaceutical Industries Ethical Pharmaceuticals Introduction 6.1.4 Teva Pharmaceutical Industries Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.1.5 Teva Pharmaceutical Industries Recent Developments 6.2 GlaxoSmithKline 6.2.1 GlaxoSmithKline Company Details 6.2.2 GlaxoSmithKline Business Overview 6.2.3 GlaxoSmithKline Ethical Pharmaceuticals Introduction 6.2.4 GlaxoSmithKline Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.2.5 GlaxoSmithKline Recent Developments 6.3 Johnson & Johnson 6.3.1 Johnson & Johnson Company Details 6.3.2 Johnson & Johnson Business Overview 6.3.3 Johnson & Johnson Ethical Pharmaceuticals Introduction 6.3.4 Johnson & Johnson Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.3.5 Johnson & Johnson Recent Developments 6.4 Novartis 6.4.1 Novartis Company Details 6.4.2 Novartis Business Overview 6.4.3 Novartis Ethical Pharmaceuticals Introduction 6.4.4 Novartis Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.4.5 Novartis Recent Developments 6.5 Pfizer 6.5.1 Pfizer Company Details 6.5.2 Pfizer Business Overview 6.5.3 Pfizer Ethical Pharmaceuticals Introduction 6.5.4 Pfizer Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.5.5 Pfizer Recent Developments 6.6 Sanofi 6.6.1 Sanofi Company Details 6.6.2 Sanofi Business Overview 6.6.3 Sanofi Ethical Pharmaceuticals Introduction 6.6.4 Sanofi Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.6.5 Sanofi Recent Developments 6.7 Merck 6.7.1 Merck Company Details 6.7.2 Merck Business Overview 6.7.3 Merck Ethical Pharmaceuticals Introduction 6.7.4 Merck Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.7.5 Merck Recent Developments 6.8 AstraZeneca 6.8.1 AstraZeneca Company Details 6.8.2 AstraZeneca Business Overview 6.8.3 AstraZeneca Ethical Pharmaceuticals Introduction 6.8.4 AstraZeneca Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.8.5 AstraZeneca Recent Developments 6.9 Bristol-Myers Squibb 6.9.1 Bristol-Myers Squibb Company Details 6.9.2 Bristol-Myers Squibb Business Overview 6.9.3 Bristol-Myers Squibb Ethical Pharmaceuticals Introduction 6.9.4 Bristol-Myers Squibb Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.9.5 Bristol-Myers Squibb Recent Developments 6.10 Eli Lilly 6.10.1 Eli Lilly Company Details 6.10.2 Eli Lilly Business Overview 6.10.3 Eli Lilly Ethical Pharmaceuticals Introduction 6.10.4 Eli Lilly Ethical Pharmaceuticals Revenue in United States Market (2016-2021) 6.10.5 Eli Lilly Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Ethical Pharmaceuticals Market Opportunities & Trends in United States Market Table 2. Ethical Pharmaceuticals Market Drivers in United States Market Table 3. Ethical Pharmaceuticals Market Restraints in United States Market Table 4. Key Players of Ethical Pharmaceuticals in United States Market Table 5. Top Ethical Pharmaceuticals Players in United States Market, Ranking by Revenue (2019) Table 6. United States Ethical Pharmaceuticals Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Ethical Pharmaceuticals Revenue Share by Companies, 2016-2021 Table 8. Companies Ethical Pharmaceuticals Product Type Table 9. List of Tier 1 Ethical Pharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Ethical Pharmaceuticals Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – United States Ethical Pharmaceuticals Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Ethical Pharmaceuticals Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Ethical Pharmaceuticals Revenue (US$, Mn), 2022-2027 Table 14. By Application – United States Ethical Pharmaceuticals Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Ethical Pharmaceuticals Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Ethical Pharmaceuticals Revenue (US$, Mn), 2022-2027 Table 17. Teva Pharmaceutical Industries Company Details Table 18. Teva Pharmaceutical Industries Business Overview Table 19. Teva Pharmaceutical Industries Ethical Pharmaceuticals Product Table 20. Teva Pharmaceutical Industries Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Teva Pharmaceutical Industries Recent Developments Table 22. GlaxoSmithKline Company Details Table 23. GlaxoSmithKline Business Overview Table 24. GlaxoSmithKline Ethical Pharmaceuticals Product Table 25. GlaxoSmithKline Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 26. GlaxoSmithKline Recent Developments Table 27. Johnson & Johnson Company Details Table 28. Johnson & Johnson Business Overview Table 29. Johnson & Johnson Ethical Pharmaceuticals Product Table 30. Johnson & Johnson Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Johnson & Johnson Recent Developments Table 32. Novartis Company Details Table 33. Novartis Business Overview Table 34. Novartis Ethical Pharmaceuticals Product Table 35. Novartis Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Novartis Recent Developments Table 37. Pfizer Company Details Table 38. Pfizer Business Overview Table 39. Pfizer Ethical Pharmaceuticals Product Table 40. Pfizer Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Pfizer Recent Developments Table 42. Sanofi Company Details Table 43. Sanofi Business Overview Table 44. Sanofi Ethical Pharmaceuticals Product Table 45. Sanofi Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Sanofi Recent Developments Table 47. Merck Company Details Table 48. Merck Business Overview Table 49. Merck Ethical Pharmaceuticals Product Table 50. Merck Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Merck Recent Developments Table 52. AstraZeneca Company Details Table 53. AstraZeneca Business Overview Table 54. AstraZeneca Ethical Pharmaceuticals Product Table 55. AstraZeneca Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 56. AstraZeneca Recent Developments Table 57. Bristol-Myers Squibb Company Details Table 58. Bristol-Myers Squibb Business Overview Table 59. Bristol-Myers Squibb Ethical Pharmaceuticals Product Table 60. Bristol-Myers Squibb Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 61. Bristol-Myers Squibb Recent Developments Table 62. Eli Lilly Company Details Table 63. Eli Lilly Business Overview Table 64. Eli Lilly Ethical Pharmaceuticals Product Table 65. Eli Lilly Ethical Pharmaceuticals Revenue in United States Market (2016-2021) & (US$ Million) Table 66. Eli Lilly Recent Developments List of Figures Figure 1. Ethical Pharmaceuticals Segment by Type Figure 2. Ethical Pharmaceuticals Segment by Application Figure 3. United States Ethical Pharmaceuticals Market Overview: 2020 Figure 4. United States Ethical Pharmaceuticals Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Ethical Pharmaceuticals Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Ethical Pharmaceuticals Revenue in 2020 Figure 7. By Type - United States Ethical Pharmaceuticals Revenue Market Share, 2016-2027 Figure 8. By Application - United States Ethical Pharmaceuticals Revenue Market Share, 2016-2027 Figure 9. Teva Pharmaceutical Industries Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. GlaxoSmithKline Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Johnson & Johnson Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Novartis Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Pfizer Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Sanofi Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Merck Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. AstraZeneca Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. Bristol-Myers Squibb Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. Eli Lilly Ethical Pharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Teva Pharmaceutical Industries GlaxoSmithKline Johnson & Johnson Novartis Pfizer Sanofi Merck AstraZeneca Bristol-Myers Squibb Eli Lilly